Appendix table: Comparison of ADAMTS13 assays in plasma and serum
| Patient . | Immunoblotting assay (% activity) . | FRETS-VWF73 assay (% activity) . | ||
|---|---|---|---|---|
| Plasma . | Serum . | Plasma . | Serum . | |
| A | < 5 | < 5 | < 5 | < 5 |
| B | 60 | 70 | 92 | 105 |
| C | 30 | 30 | 62 | 74 |
| D | < 5 | < 5 | < 5 | < 5 |
| E | < 5 | < 5 | < 5 | < 5 |
| F | 42.5 | 50 | 54 | 59 |
| G | 60 | 60 | 55 | 60 |
| H | 85 | 80 | 95 | 115 |
| I | < 5 | 7 | < 5 | < 5 |
| J | 60 | 75 | 58 | 66 |
| K | 10 | 7 | 7 | 9 |
| L | 60 | 70 | 91 | 97 |
| M | 27.5 | 35 | 33 | 31 |
| Patient . | Immunoblotting assay (% activity) . | FRETS-VWF73 assay (% activity) . | ||
|---|---|---|---|---|
| Plasma . | Serum . | Plasma . | Serum . | |
| A | < 5 | < 5 | < 5 | < 5 |
| B | 60 | 70 | 92 | 105 |
| C | 30 | 30 | 62 | 74 |
| D | < 5 | < 5 | < 5 | < 5 |
| E | < 5 | < 5 | < 5 | < 5 |
| F | 42.5 | 50 | 54 | 59 |
| G | 60 | 60 | 55 | 60 |
| H | 85 | 80 | 95 | 115 |
| I | < 5 | 7 | < 5 | < 5 |
| J | 60 | 75 | 58 | 66 |
| K | 10 | 7 | 7 | 9 |
| L | 60 | 70 | 91 | 97 |
| M | 27.5 | 35 | 33 | 31 |